You are here
- Home
- A-Z Index and Glossary
- Controlled Substances
Controlled Substances
-
- Advance Notice: Changes to DEA Form-222
- Buprenorphine Recall – MWI (Animal Health Distributor)
- Changes to State of Michigan Requirements for Annual Controlled Substances Inventory
- Changes to the Disposal Process for Schedules I and II Controlled Substances in Research
- DEA Announces Changes in Registration Renewal Notifications
- DEA Registrants: Be on Alert for Increased Scamming Attempts
- Do You Know What to Do if the State of Michigan or DEA Show Up?
- Drug Supplies and Shortages Due to COVID-19: Impact on Animal Research at U-M
- First Annual GOLD Day
- GOLD Day Coming this May
- Important Expectations & Updates: Use of Expired Drugs and Medical Materials in Animals
- Ketamine-Xylazine Mixture from Sigma-Aldrich Corporation
- Monitoring Controlled Substances in Research Town Hall
- Monitoring Controlled Substances in Research Town Hall
- New Resources to Promote Responsible Use of Drugs and Other Medical Materials
- Notice: Emergency Federal DEA Scheduling of All Non-Scheduled Fentanyl Analogs
- Ordering Ketamine for Use in Animals
- Propofol to Be Handled As Controlled Substance Effective August 1
- Ramp-Up Reminder: Verify Controlled Substances and Related Documentation
- Reminder: Three-Page DEA Form 222 to Be Replaced in October
- Research Controlled Substances: State of Michigan and DEA Audit Preparedness
- Single-Page DEA Form 222 Now Required for Schedule I and II Controlled Substances
- State of Michigan Annual Controlled Substance Inventory Due
- State of Michigan Annual Controlled Substance Inventory Due July 14
- UMOR Controlled Substances Monitoring Program Introduces Revised Escalation Plan
- Virtual AAALAC Chat: Management of Controlled Substances in Animal Research